Comparison on the Blood Glucose Fluctuation of Three Combination Therapy Scheme of Insulin Aspart 30 for Patients with Type 2 Diabetes
Lu Li
Abstract
Lu Li
Abstract
Objective: To compare the blood glucose fluctuation of three combination therapy scheme of insulin aspart 30 in type 2 diabetes subjects.Methods: The subjects with type 2 diabetes were divided into 3 groups randomly.Group A: insulin aspart 30 injection,twice daily,plus metformin tablets;Group B: insulin aspart 30 injection,three times daily,plus metformin tablets;Group C: insulin aspart 30 injection,twice daily,plus metformin and acabose tablets.The efficacy and safety economic data were collected and analyzed.Results: The blood glucose of three groups all dropped obviously,and the efficacy and safety were similar in 3 groups.There is no significant diference among three groups,but there were obvious differences among three groups in SDBG,B groupC groupA group,(F=6.02,P0.01);blood glucose before supper of group A showed highest,(7.14±1.06mmol/L,F=5.63,P0.05).Conclusion: The blood glucose fluctuation of scheme B showed least.Scheme A showed poorer control of the blood glucose before supper,compared with scheme B and C.Scheme C showed the shortest time to decrease blood glucose in early-stage.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To compare the blood glucose fluctuation of three combination therapy scheme of insulin aspart 30 in type 2 diabetes subjects.Methods: The subjects with type 2 diabetes were divided into 3 groups randomly.Group A: insulin aspart 30 injection,twice daily,plus metformin tablets;Group B: insulin aspart 30 injection,three times daily,plus metformin tablets;Group C: insulin aspart 30 injection,twice daily,plus metformin and acabose tablets.The efficacy and safety economic data were collected and analyzed.Results: The blood glucose of three groups all dropped obviously,and the efficacy and safety were similar in 3 groups.There is no significant diference among three groups,but there were obvious differences among three groups in SDBG,B groupC groupA group,(F=6.02,P0.01);blood glucose before supper of group A showed highest,(7.14±1.06mmol/L,F=5.63,P0.05).Conclusion: The blood glucose fluctuation of scheme B showed least.Scheme A showed poorer control of the blood glucose before supper,compared with scheme B and C.Scheme C showed the shortest time to decrease blood glucose in early-stage.
Key concepts: Medicine, Insulin aspart, Metformin, Internal medicine, Type 2 diabetes, Insulin, Group B, Diabetes mellitus